Home
Conditions
Skin Neoplasms

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,110 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Recruiting

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

NCT03340129

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations: Westmead Hospital Sydney, New South Wales, Australia

Calvary Mater NewcastleHospital Waratah, New South Wales, Australia

Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

View Trial Details

Recruiting

A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

NCT07376707

Conditions: Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

NCT07371663

Conditions: Ataxia, Ataxia Telangiectasia, Brain Diseases, +60 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

NCT06599619

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysplastic Nevus Syndrome, +23 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

NCT07221734

Conditions: Advanced (Unresectable or Metastatic) Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations: Site 111003 Funchal, Portugal

Site 117015 Chernivtsi, Ukraine

Site 117005 Ivano-Frankivsk, Ukraine

Site 117002 Kyiv, Ukraine

View all 19 locations

View Trial Details

Recruiting

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

NCT07317505

Conditions: Cancer, Cancer (Solid Tumors), Colonic Diseases, +24 more
Locations: Carolina BioOncology Institute Huntersville, North Carolina, United States

NEXT Dallas Dallas, Texas, United States

NEXT Virginia Fairfax, Virginia, United States

View Trial Details

Recruiting

Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

NCT07349303

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Recruiting

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

NCT06199713

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations: University of Wisconsin Hospitals and Clinics (UWHC) Madison, Wisconsin, United States

View Trial Details

Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

NCT07318051

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +61 more
Locations: Natera, Inc. Austin, Texas, United States

View Trial Details

Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

NCT06887348

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +20 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Tasman Oncology Research Southport, Queensland, Australia

View Trial Details

Skin Neoplasms

Skin Neoplasms trial results

Related conditions